We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Home
Services
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
E3 Holding AG, Germany, has acquired the clean-tek group from Felix Ritter.
Clean-tek is one of the pioneers in cleanroom technology - technology for sensitive areas such as pharmaceutical production, medical technology,...
The AMR Action Fund, the world's largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys AG, a clinical-stage company based in Basel, Switzerland.
Invision has launched and successfully closed Invision Logistics LP, a CHF 145m continuation fund for the further development of Schneider Group.
Resistell AG, a leader in phenotypic nanomotion technology for measuring living cells, based in Muttenz, Switzerland, has taken another major step to achieving its vision by closing a first tranche of its series B financing round raising CHF 8.5m from new and existing investors.
AFINUM has sold its stake in Cotta Collection AG Upholstered Furniture-Group to L-GAM and to Gschwend AG.
Cotta is a manufacturer of upholstered furniture in the low to medium price segment with two plants in Poland and one plant in Romania.
On 15 November 2022, Hangzhou GreatStar Industrial Co., Ltd., whose A Shares are listed on the Shenzhen Stock Exchange, became the eighth Chinese company that has listed global depositary receipts (GDRs) on the SIX Swiss Exchange.
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative.
Oculis, SA, a global biopharmaceutical company developing treatments to save sight and improve eye care with breakthrough innovations and European Biotech Acquisition Corp (NASDAQ: EBAC), a special purpose acquisition company (SPAC), announced they have entered into a definitive business combination agreement.
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.
Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases is to be sold to Genfit SA (NASDAQ: GNFT).
Displaying results 1 to 10 out of 442